Spot on, Huw has made a really smart move here and shows the mettle of the CEO we have now. Just a shame he couldn't find more than £5k to participate in the placing, which would have sweetened the deal that little bit more.
Treatment period is 14 days then assessment on the 15th day. So if the DSMB takes say another 10 days to do the analysis we could be looking at the 1st week of March for that news.
DSMB will make the assessment on the data from 100 treated patients. Treatment time is 14 days I believe, so yes it's possible it will be in by the end of the month.
Short-sighted selling now. They now have or will shortly have £11m extra cash and the SP has hardly changed - in fact it's risen. SNG did a similar placing during their trial although not as dilutive. Anyway they're fully funded now to agressively pursue multiple prospects, and the big boys have got their share so hopefully no more shenanigans with the SP.
To be fair if you listen again in hindsight he chose his words very carefully “funded until later in the year for current operations” or words to that effect. The broker note gave the clue they wanted to expand and accelerate those operations.
Given it was "heavily subscribed" and "brought new, high quality shareholders" - I would be rather suprised if the likes of spreadex got let in on the action?
Spreadex holdings are just the total of individual spread-betters surely.
Anyway some good news buried in that - COVID trial recruitment looks set to hit 100 patients at the end of this week - should get an RNS next Monday I would imagine.
Frustrating share to hold this. Persons unknown seem willing to keep selling at low prices, but nobody ever comes up with a reason on here or the other site why you would sell at this valuation.
Yes in the recent interview Huw said they would update the market when the 100 was reached and remind the market about the DSMB assessment (including hopefully an expected timescale) at that point.